Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer by Maroun Bou Zerdan, Prashanth Ashok Kumar, Dulce M. Barrios, Alanna Glidden, Dayana Nasr, Stephanie Niforatos, Ghanshyam Ghelani, Jennifer Leibovitch, Sandy Nasr, Binod KC, Mulham Ombada, Farzam Khokhar, Bhavya Poudyal, Jenish Bhandari, Myera Shahnawaz, Stephen Graziano, Seah H. Lim

Get full text